美国 · 平台与数据 · MarketBeat

Krystal Biotech (NASDAQ:KRYS) Given New $412.00 Price Target at Citigroup

来源：MarketBeat · 美国 1 小时前

Citigroup decreased their price objective on shares of Krystal Biotech from $416.00 to $412.00 and set a "buy" rating on the stock in a report on Tuesday.

在 MarketBeat 阅读全文登录后可收藏

MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (www.marketbeat.com)

Krystal Biotech (NASDAQ:KRYS) Given New $412.00 Price Target at Citigroup

推荐阅读

AIRO Group offers upside as military drone demand accelerates: Roth Capital

ServiceNow Stock: Buy the Dip?

My wife and I have no kids and a 99% chance of outliving our life savings. Why not spend it all?

Stock market after midterm elections: What S&P 500 history shows

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030

3 Vanguard Bond ETFs That Mail Retirees a Check Every Month. Here’s What They Paid

Krystal Biotech (NASDAQ:KRYS) Given New $412.00 Price Target at Citigroup

分享

推荐阅读

AIRO Group offers upside as military drone demand accelerates: Roth Capital

ServiceNow Stock: Buy the Dip?

My wife and I have no kids and a 99% chance of outliving our life savings. Why not spend it all?

Stock market after midterm elections: What S&P 500 history shows

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030

3 Vanguard Bond ETFs That Mail Retirees a Check Every Month. Here’s What They Paid